This presentation will focus on these injectables to achieve the best possible esthetic and therapeutic outcomes. An understanding of facial anatomy, the aging process, and safety issues for injectable therapy is needed to diagnose and recommend aesthetic treatment plans. A review of neurotoxins and dermal fillers, including the mechanism of action, side effects, expected results, and complications with protocols will be discussed. | 1.00 credits (1.00 pharmacology) | $30

The 2018 Agricultural Improvement Act (Farm Bill 2018) authorized by Congress made hemp products containing less than 0.3% tetrahydrocannabinol (THC) legal. However, contrary to popular belief, this bill did not authorize the legal sale of cannabidiol (CBD) products for promotion of any traditional health benefits, yet the sale of CBD products across the United States has significantly increased following its passage. There is currently no formal regulation on CBD products being sold in the United States beyond Epidiolex® which is specifically regulated as a drug via the FDA. Pharmacists need to understand the basics of how CBD acts on the human body, which health claims have been proven via robust clinical trials, and the potential adverse effects and drug interactions that may occur in a patient who uses these unregulated products in conjunction with their prescribed or over-the-counter medication regimen. Pharmacists also need to be able to provide information regarding the sale and regulation of CBD products and the potential issues that may arise given the current legal status of CBD products. | 1.50 credits (1.50 pharmacology) | $40.00

Presentation of Case Studies in Neurology that may be seen in the primary care setting. The case studies will discuss determining the appropriate neurological assessment and evaluation of findings. Each case study will progress through confirming the diagnosis and planning for the patient. These case studies will include seizure disorder, restless leg syndrome, Parkinson disease, muscle spasms. | 1.0 credits (0.33 pharmacology) | $30

Over the past 10 years, many of the options available to treat osteoarthritis and rheumatoid arthritis have come under scrutiny. Many products have been pulled from the market. Throughout this lecture, Ms. Wright will discuss the pathophysiology of osteoarthritis and rheumatoid arthritis. In addition, all pharmacologic therapies currently utilized for patients with both OA and RA will be discussed including their use, side effects, benefits, and drug-drug interactions. | 1.50 credits (1.50 pharmacology) | $45